Given the multi-systemic nature of this disease, it is currently difficult for clinicians to accurately monitor and assess the optimal timing of treatment as well as the effect of treatment and its duration.This study is the first time that the imaging technique, FDG PET - CT, has been used to assess
the combined lung structure and metabolic activity in a patient with GLILD before and after treatment.
More deaths could be stopped, if doctors were able to catch the disease in its early stages, but the
lung's complex
structures,
combined with current techniques, make the process difficult.